Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2014A0067740 | Registry Identifier | RCB number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The bullous pemphigoid treatment is based on corticosteroids continued for several years. Pemphigus causes some patients a psychological impact and sometimes major vulnerability that can occur not only at diagnosis but also at later stages of disease progression. Our hypothesis is that these episodes of vulnerability may be under four kinds of factors that may be connected to the plurality of the history of these patients, and the resources they can mobilize throughout this experience, generating inequality in management and "work" around the disease.
The originality of the project lies in its multidisciplinary approach (dermatology, psychology, sociology). No such study has yet been carried out in the pemphigus who has been the subject of a very small number of works in sociology or psychology. The only studies are studies of quality of life with no longitudinal follow-up. The perspective of qualitative and quantitative data, sociological and psychological approaches, should allow more innovative and adapted to the medico-social and psychological care of patients with pemphigus approaches. The purpose of this study is to identify the determinants leading to moments of vulnerability in the course of patients with pemphigus in order to be able to offer preventive or corrective actions to improve the experience of the disease.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| prevalent cases | Experimental | 40 prevalent cases correspond to patients with known pemphigus. Emphasis will be on included patients at different times of the course of their disease. 8 incident cases recruited through the center of Rouen and following an intervention program with psychological support and therapeutic education program |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| psychological support and therapeutic education program | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| analysis of vulnerability factors | evaluation of : perception by the patient of misdiagnosis, perception of a possible difference in assessment of the severity of his illness between himself and healthcare professionals, patient behavior in relation to available information sources, and the influence of information gathered on the illness experience, Patient trajectory during the diagnostic phase using individual interview and questionnaire | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| analysis of vulnerability factors | evaluation of : perception by the patient of misdiagnosis, perception of a possible difference in assessment of the severity of his illness between himself and healthcare professionals, patient behavior in relation to available information sources, and the influence of information gathered on the illness experience, Patient trajectory during the diagnostic phase using individual interview and questionnaire |
Not provided
Inclusion Criteria:
Patient major
Patients with pemphigus vulgaris, diagnosed on a combination of:
Join a social security scheme
patient has been informed and have signed consent to participate in the study
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pascal Joly, Professor | University Hospital, Rouen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Avicenne | Bobigny | 93000 | France | |||
| CHU de Clermont-Ferrand Hôpital d'Estaing |
Not provided
| ID | Term |
|---|---|
| D010392 | Pemphigus |
| D012871 | Skin Diseases |
| ID | Term |
|---|---|
| D012872 | Skin Diseases, Vesiculobullous |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| assessment of anxiety, uncertainty, fear, coping strategies | assessment of anxiety, uncertainty, fear, coping strategies using individual interview and questionnaire | 12 months |
| assessment of anxiety, uncertainty, fear, coping strategies | assessment of anxiety, uncertainty, fear, coping strategies using individual interview and questionnaire | 6 months |
| Clermont-Ferrand |
| 63003 |
| France |
| CH du Mans | Le Mans | 72037 | France |
| CHRU de Lille Hôpital Claude Huriez | Lille | 59037 | France |
| Hôpital La Timone, Assistance publique hôpitaux de Marseille-Aix | Marseille | France |
| Hôpital Haut-Lévêque | Pessac | 33604 | France |
| Centre hospitalier de Cornouaille | Quimper | 29107 | France |
| Hôpital Robert Debré, chu de Reims | Reims | 51 092 | France |
| University Hospital of Rouen | Rouen | 76031 | France |